Lymphoma represents a spectrum from indolent to aggressive disease; prognosis and management should be individualized by biologic behavior and owner goals. Avoid reflexively applying a single protocol ...

Canine lymphoma represents one of the most common haematological malignancies in dogs and is increasingly recognised as a robust comparative model for human non‐Hodgkin lymphoma. Recent efforts have ...

Panel expansion planned over the next three years to cover the majority of canine cancer cases, transforming cancer detection and supporting earlier intervention "Building on over 40 years of IDEXX's ...

Clinical trial sites across nine states have closed for one of the largest canine lymphoma studies Effectiveness data will soon be finalized for statistical review and FDA submission LONG BEACH, Calif ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA has granted full approval of a drug to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system.

"My 12-year-old dog Oliver has been diagnosed with lymphoma. Naturally, the vet has referred me to an oncology vet. I do not want to put the dog through chemo, and I asked the vet if he would treat ...

Ashleigh Tindle, a researcher involved in the project and a Ph.D. student at the University of Wisconsin-Madison, stands with a poster on her project, which evaluated the link between fracking and ...

On January 16, 2026, the U.S. Food and Drug Administration (FDA) released a statement saying they had granted full approval ...

The battle against cancer has always been a challenge. Despite the revolutionary advancements in medical science, the battle still continues to be challenging. When it comes to canine cancer, the ...

The FDA has approved Laverdia, a drug to treat dogs with lymphoma, a type of cancer of the lymph nodes and lymphatic system. Laverdia is an oral treatment and only available by prescription from a ...